ING Groep NV cut its stake in Clorox Co. (NYSE:CLX) by 19.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,776 shares of the company’s stock after selling 1,869 shares during the period. ING Groep NV’s holdings in Clorox were worth $1,076,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Bank of Montreal Can acquired a new stake in shares of Clorox during the second quarter valued at $53,902,000. BlackRock Institutional Trust Company N.A. increased its stake in shares of Clorox by 7.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,504,422 shares of the company’s stock valued at $567,827,000 after buying an additional 313,224 shares during the last quarter. BlackRock Group LTD increased its stake in shares of Clorox by 18.2% in the first quarter. BlackRock Group LTD now owns 1,592,689 shares of the company’s stock valued at $200,775,000 after buying an additional 245,650 shares during the last quarter. Bessemer Group Inc. increased its stake in shares of Clorox by 446.4% in the first quarter. Bessemer Group Inc. now owns 276,686 shares of the company’s stock valued at $34,879,000 after buying an additional 226,050 shares during the last quarter. Finally, First Quadrant L P CA increased its stake in shares of Clorox by 955.1% in the second quarter. First Quadrant L P CA now owns 195,200 shares of the company’s stock valued at $27,014,000 after buying an additional 176,700 shares during the last quarter. Hedge funds and other institutional investors own 70.21% of the company’s stock.
Clorox Co. (NYSE:CLX) traded down 0.07% during mid-day trading on Friday, hitting $122.65. The stock had a trading volume of 974,005 shares. The stock has a market cap of $15.88 billion, a P/E ratio of 24.93 and a beta of 0.29. The firm has a 50-day moving average of $126.61 and a 200-day moving average of $129.88. Clorox Co. has a 52-week low of $119.23 and a 52-week high of $140.47.
Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the company posted $1.44 earnings per share. The company’s revenue was up 2.8% on a year-over-year basis. On average, analysts forecast that Clorox Co. will post $5.49 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Investors of record on Wednesday, October 26th will be issued a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s dividend payout ratio is presently 64.91%.
Several equities research analysts have recently weighed in on CLX shares. Atlantic Securities upgraded Clorox from a “hold” rating to a “buy” rating and set a $144.00 price target on the stock in a report on Friday, September 16th. Goldman Sachs Group Inc. restated a “neutral” rating and set a $130.00 price objective on shares of Clorox in a report on Thursday, August 4th. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $148.00 price objective on the stock in a report on Monday, August 8th. Citigroup Inc. raised their price objective on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a report on Monday, August 8th. Finally, Deutsche Bank AG restated a “hold” rating and set a $134.00 price objective (up from $130.00) on shares of Clorox in a report on Sunday, July 24th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $128.90.
In other Clorox news, COO Nikolaos A. Vlahos sold 925 shares of the company’s stock in a transaction on Wednesday, August 10th. The stock was sold at an average price of $133.07, for a total transaction of $123,089.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Jon M. Balousek sold 5,136 shares of the company’s stock in a transaction on Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the transaction, the senior vice president now owns 15,384 shares in the company, valued at $2,017,457.76. The disclosure for this sale can be found here. 0.74% of the stock is owned by corporate insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.